Avenue Therapeutics Inc (ATXI)
3.35
-0.03
(-0.89%)
USD |
NASDAQ |
Jun 10, 15:47
Avenue Therapeutics Cash from Investing (Quarterly)
Cash from Investing (Quarterly) Chart
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 0.00 |
| September 30, 2023 | -1.00M |
| June 30, 2023 | -2.00M |
| March 31, 2023 | |
| December 31, 2022 | 0.00 |
| September 30, 2022 | 0.00 |
| June 30, 2022 | 0.00 |
| March 31, 2022 | |
| December 31, 2021 | |
| September 30, 2021 | |
| June 30, 2021 | |
| March 31, 2021 | |
| December 31, 2020 | 0.00 |
| September 30, 2020 | 0.00 |
| June 30, 2020 | 0.00 |
| Date | Value |
|---|---|
| March 31, 2020 | -1.00M |
| December 31, 2019 | 5.00M |
| September 30, 2019 | 0.00 |
| June 30, 2019 | -5.00M |
| March 31, 2019 | 0.00 |
| December 31, 2018 | 0.00 |
| September 30, 2018 | 0.00 |
| June 30, 2018 | 0.00 |
| March 31, 2018 | 10.00M |
| December 31, 2017 | 0.00 |
| September 30, 2017 | -10.00M |
| June 30, 2017 | 0.00 |
| March 31, 2017 | 0.00 |
| December 31, 2016 | 0.00 |
| September 30, 2016 | 0.00 |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
-5.00M
Minimum
Jun 2019
5.00M
Maximum
Dec 2019
-0.3077M
Average
--
Median
Sep 2019
Cash from Investing (Quarterly) Benchmarks
| Fortress Biotech Inc | 0.00 |
| SINTX Technologies Inc | -0.173M |
| Deciphera Pharmaceuticals Inc | 62.63M |
| Flora Growth Corp | -0.088M |
| NovaBay Pharmaceuticals Inc | 1.068M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -3.12M |
| Cash from Financing (Quarterly) | 4.531M |
| Free Cash Flow | -11.00M |
| Free Cash Flow Per Share (Quarterly) | -416.39 |
| Free Cash Flow Yield | -2.34K% |